Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension.

The European respiratory journal(2023)

引用 40|浏览25
暂无评分
摘要
These results support the longer-term safety and durability of clinical benefit of sotatercept for pulmonary arterial hypertension.
更多
查看译文
关键词
pulmonary arterial hypertension,pulsar,open-label
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要